TP53 and familial pancreatic carcinoma: In the present study, 54% of pancreatic cancers were P53-positive and this is consistent with previous reports of 47% (Bold et al, 1999), 54% (Sinicrope et al, 1996) and 64% (Hu et al, 1998).